email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2926 - 2940
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Shanghai Pharma Acquires Majority Stake in JV Techpool in $280 Million Deal
$5.00
Available
WuXi Biologics Invests $60 Million in Another New Plant -- In Singapore This Time
$5.00
Available
Grail Raises $300 Million from China Investors for Early Cancer Diagnostics
$5.00
Available
Legend Capital Closes $156 Million Phase II for RMB Healthcare Fund
$5.00
Available
Salubris Acquires China Rights to MedAlliance CV Balloon for $30 Million
$5.00
Available
CR Pharma in Talks for $613 Million Acquisition of Jiangzhong Pharma
$5.00
Available
BeiGene Starts China Trial of PARP Inhibitor in Ovarian Cancer Patients
$5.00
Available
WuXi Biologics Plans Another New CDMO Plant -- A $240 Million Facility in Shijiazhuang
$5.00
Available
Innovent Reports Positive Results for PD-1 Candidate; Files China NDA
$5.00
Available
Boston's HiFiBiO Raises $37.5 Million from China Investors
$5.00
Available
China to Extend Drug Patent Protection to 25 Years, Up from 20
$5.00
Available
Jiangsu Ambition In-licenses Prostate Treatment from Sweden's Lidds
$5.00
Available
Dongbao Pharma Acquires Two Diabetes Treatments in $135 Million Deal
$5.00
Available
Asymchem Starts Fund to Bring Novel Western Drugs to China
$5.00
Available
CStone Pharma Starts Phase I Trial of PD-1 Molecule
$5.00
Available